The unique membrane-associated inhibitor of matrix metalloproteinases, RECK, is required for vascular maturation during embryogenesis. The phenotype of a loss of function mutation of RECK shows the importance of pericellular proteolysis in development.
highly similar due to the conserved positions of twelve cysteine residues that form six disulfide bonds. Correct pairing of the six cysteine residues in the amino terminus is critical for TIMP inhibition of MMP [7, 8] .
The amino terminus of TIMP was recently predicted to be homologous to domains within other proteins having diverse functions (Figure 1 ). This protein motif, coined the NTR module, has a common feature of six conserved cysteines [9] . One predicted NTR module, CT-PCPE, inhibited MMP in vitro. Inhibition by CT-PCPE was hypothesized to occur because the folded structure of CT-PCPE was similar to TIMP [6] . Whether other NTR proteins such as Netrin and the secreted Frizzled-related proteins have MMP inhibitory activity remains to be determined. However it should be noted that chemical inhibitors of metalloproteinase activity synergize with Netrin as an axonal chemoattractant [10] .
The mechanism by which TFPI-2 inhibits MMP is not clear. Although TFPI-2 does not seem to have a classic NTR module, there is a region within TFPI-2 containing a number of cysteine residues that aligns reasonably well with the amino-terminal domain of TIMP and NTR module polypeptides (Figure 1) . RECK also contains a number of cysteine residues, however, comparison of the RECK amino acid sequence to TIMP and the NTR module does not show robust similarities. Thus, the biochemical mechanism for RECK inhibition of MMP remains to be elucidated One of the unique features of RECK is that it contains a GPI domain making it a novel membrane-targeted MMP inhibitor. The targeting of several MMP (Figure 2) . Furthermore, the GPI anchoring of RECK may target it to distinct cellular regions including caveolae or regions of cell adhesion, thus positioning it at critical sites involved in cell signaling. It is unknown whether RECK has other long-range functions as a consequence of its release from the cell surface by GPI cleaving enzymes such as glycosylphosphatidylinositol phospholipase C. These characteristics may, in part, explain some of the more profound developmental defects observed in RECK knockout mice when compared with the mild developmental phenotypes described for TIMP-1, TIMP-2, TIMP-3 and α2-macroglobulin knockout mice [11] [12] [13] [14] .
Vascular development is a key process that must occur for embryonic development to proceed. The balance between ECM breakdown and deposition is critical for endothelial cell homeostasis and contributes to vasculogenesis and angiogenesis. During vasculogenesis, periendothelial cells proliferate and migrate to form networks of immature vessels. Mural cells (precursor pericytes) stimulate vascular maturation by stabilizing nascent vessels through the deposition of ECM [15] . The ECM can have multiple effects on endothelial cells including inhibiting proliferation and migration suggesting that modulating MMP processing and proteolytic activity is critical for vascular maturation. Indeed, during development RECK is expressed in large blood vessels and mural cells [2] similar to the pericyte marker smooth muscle α-actin.
Thus expression of RECK in pericytes positions it to elicit potent and concentrated inhibitory effects on MMP-9, MT1-MMP and MMP-2 activity near endothelial cells.
In the absence of RECK, increased proteolytic activity would be expected to result in ECM degradation and the destabilization of nascent vessels. This effect is seen in reck -/-embryos that display an embryonic lethality at about 10.5 days and a defect in vascular maturation [2] . Moreover, it is noteworthy that embryonic survival can be extended by one day, a significant delay at this critical stage of vascular development, when reck -/-mice are bred into the MMP-2 -/-background suggesting that abrogating MMP-2 activity partially rescues the phenotype [2] . The question remains as to whether activity of the other two MMPs -MMP-9 and MT1-MMP -can account for the remaining phenotype, or whether RECK has other enzymatic targets such as other MMPs, or members of the metalloproteinase superfamily such as ADAMs, ADAM-TSs or Tolloid-related Astascins [2] .
One function of the ECM -once thought to be its only function -is to provide a physical barrier between tissue compartments. ECM is also an important reservoir of growth, differentiation and angiogenic factors, and cleavage of ECM can produce fragments that have distinct biological activities [16] . During invasive developmental growth, for example during angiogenesis, restructuring of the ECM is required for blood vessel migration and intrusion into neighboring tissue. ECM degradation also occurs during pathological events including tumor growth and invasion, and ECM degrading proteases such as MMPs are involved in these processes. Upregulated MMP expression is seen in almost all human cancers and their expression generally correlates with poor prognosis and with malignant transformation [17] . The converse correlation Is RECK a tumor suppressor? RECK was originally identified as a gene that can revert the transforming phenotype of ras transformed NIH3T3 cells [3] . Interestingly, RECK mRNA expression in culture is inhibited by ras as well as by several other oncogenes commonly found altered in tumors including myc, mos, fos and src [3] . Furthermore, RECK expression is low or absent in several tumor cell lines, and RECK reduces invasiveness and metastatic potential when transfected into metastatic fibrosarcoma and melanoma cells lines [3] . In human hepatocellular carcinoma samples, RECK expression correlates with less invasive tumors as well as better prognostic outcome [18] . Further genetic analysis of RECK in human tumors is needed to determine if this gene is truly a tumor suppressor, but with the limited data we already have, it is intriguing to speculate that an MMP inhibitor may one day obtain this classification.
